期刊文献+

小剂量环磷酰胺对正常小鼠CD4^+CD25^+Treg细胞的调节作用 被引量:6

Regulatory effect of low dose cyclophosphamide on CD4^+CD25^+ Treg cells in mice
下载PDF
导出
摘要 目的比较多次与单次应用小剂量环磷酰胺(CTX)对小鼠CD4+CD25+调节性T细胞(Treg)数量及功能的影响,明确小剂量CTX可否多次用于下调Treg细胞。方法 C57BL/6小鼠32只,随机分为正常对照、单次、两次及三次CTX注射组共4组,各组每10天腹腔注射20 mg/kg CTX或等体积PBS,末次给药后3 d,流式细胞技术测小鼠脾细胞中Treg细胞占CD4+T细胞百分比;同时3-2,5-二苯基四氮唑溴盐(MTT)法比较各组脾细胞中T、B细胞增殖功能,中性红吞噬试验比较各组巨噬细胞吞噬功能。结果各实验组小鼠脾细胞中Treg细胞占CD4+T细胞百分比显著低于对照组(P<0.05),而各实验组间差异无统计学意义(P>0.05)。各实验组T、B细胞增殖指数及巨噬细胞吞噬功能明显高于对照组(P<0.05),但各实验组间差异无统计学意义(P>0.05)。应用CTX后Treg细胞数量与T、B细胞增殖功能及巨噬细胞吞噬功能呈线性负相关。结论多次与单次小剂量应用CTX对小鼠Treg细胞数量的下调作用无差异,下调Treg细胞后对免疫细胞的调节功能也无差异,小剂量CTX可多次用于下调正常小鼠Treg细胞。 In order to compare the number and function alteration of CD4+CD25+ regulatory T cell treated with low dose cyclophosphamide in mouse,and determine whether low dose cyclophosphamide can be used to down regulate Treg cell repeatedly,thirty-two C57BL /6 mice were randomly divided into four groups: control,once,twice and thrice treated groups.Mice in groups were injected intraperitoneally with 20 mg/kg Cyclophosphamide(CTX) or equal volume PBS every ten days.Three days after the last injection,the ratio of Treg cells to CD4+ T cells in spleen was detected by flow cytometry;the proliferation of T and B lymphocytes were detected by 3-2,5-diphenyl-tetrazolium bromide(MTT) test;and the phagocytosis of macrophages was detected by neutral red test.Compared to control group,the percentage of Treg cell in CD4+T cells of treated groups decreased sharply(P 0.05),but there was no difference between the treated groups(P 0.05).The proliferation of T and B lymphocytes and the phagocytosis of macrophages were all enhanced,as compared with control group(P 0.05),but there was no difference between the treated groups(P 0.05).We also found that the number of Treg cells negatively correlated with the proliferation of T/B lymphocytes and the phagocytosis of macrophages after administrating with CTX.All these results indicate that there is no difference in decreasing Treg cell and regulating the function of immunocells subsequently between the single and multi-administration with low dose cyclophosphamide.Thus low dose cyclophosphamide could be used to down regulate Treg cell repeatedly.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第4期292-296,共5页 Immunological Journal
基金 山西省科技攻关项目(20090311057-7) 山西医科大学创新基金(01200902)
关键词 环磷酰胺 CD4+CD25+调节性T细胞 免疫疗法 Cyclophosphamide CD4+CD25+ Treg cells Immunotherapy
  • 相关文献

参考文献15

  • 1Sakaguchi S, Saka guchi N, Asano M. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 recept or alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol, 1995, 155(3):1151-1164.
  • 2Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma [J]. J Immunol, 2002, 169(5):2756-2761.
  • 3Ghiringheli F, l,armonier N, Schmitt E, el al. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative [J]. Eur J Immunol, 2004, 34(2): 336-344.
  • 4甘长清,王小毅.CD4^+CD25^+调节性T细胞和Foxp3在不同病理类型乳腺癌患者外周血和组织中表达水平及其临床意义[J].免疫学杂志,2009,25(3):322-325. 被引量:9
  • 5Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses [J]. J Exp Med, 2001, 194(6):823-832.
  • 6赵弋清,罗霞,陈东辉,余梦瑶,杨志荣.不同剂量环磷酰胺诱导正常小鼠免疫抑制的对比研究[J].免疫学杂志,2005,21(B06):122-124. 被引量:82
  • 7Ikezawa Y, Nakazawa M, Tamura C, et al. Cyclophosphamide decreases the number, percentage and the function of CD25+CD4+regulatory T cells, which suppress induction of contact hypersensitivity [J]. J Dermatol Sci, 2005, 39 (2): 105-112.
  • 8Motoyoshi Y, Kminoda K, Saitoh O, et al. Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide [J]. Oncol Rep, 2006,16(1):141-146.
  • 9Liu JY, Wu Y, Zhang XS, et al. Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine [J]. Cancer Immunol Immunother, 2007, 56(10): 1597-1604.
  • 10Di Paolo NC, Tuve S, Ni S, et al. Effect of adenovirus mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on anti-tumor immune responses [J]. Cancer Res, 2006, 66 (2): 960-969.

二级参考文献27

  • 1[1]Stephens GL,Shevach EM.FaxpT regulatoiy T cells:selfishness under scrutiny[J].Inmunity,2007,27(3):417-419.
  • 2[2]Kurooka M,Kaneda Y.Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells[J].Cancer Res,2007,67(1):227-236.
  • 3[3]Liu L,Wu G,Yao JX,et al.CD4+ CD25high regulatory cells in peripheral blood of cancer patients[J].Neuro Endocrinol Lett,2008,29(2):240-245.
  • 4[4]Kono K,Kawaida H,Takahashi A,et al.CD4(+)CD25 (high)regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers[J].Cancer Immunol Immunother,2006,55(9):1064-1071.
  • 5[5]Hong J,Li N,Zhang X,et al.Induction of CD4+ CD25 + regulatory T cells by copolymer-I through activation of transcription factor Foxp3[J].Proc Natl Acad Sci US A,2005,102(18):6449-6454.
  • 6[6]Zheng SG,Wang JH,Stohl W,et al.TGF beta requires CTLA-4 early after T cell activation to induce Foxp3 and generate adaptive CD4+ CD25+ regulatory cells[J].J Immunol,2006,176(6):3321-3329.
  • 7[7]Sakaguchi S,Ono M,Setoguchi R,et al.Foxp3+ CD25 + CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease[J].Immunol Rev,2006,8:8-27.
  • 8[8]Kim JM,Rudensky A.The role of the transcription factor Foxp3 in the development of regulatory T cells[J].Immunol Rev,2006,212:86-98.
  • 9[10]Connolly JL.Changes and problematic areas in interpretation of the AJCC Cancer Staging Manual,6th Edition,for breast cancer[J].Arch Pathol Lab Med,2006,130(3):287-291.
  • 10[11]Ramsdell F,Ziegler SF.Transcription factors in autoimmunity[J].CurrOpin Immunol,2003,15(6):718-724.

共引文献89

同被引文献51

引证文献6

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部